Sandy Hook, CT, United States of America

Jin Mi Kim


 

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Journey of Jin Mi Kim: A Pioneer in Chymase Inhibitors

Introduction

Jin Mi Kim is a distinguished inventor based in Sandy Hook, Connecticut. With an impressive portfolio of 11 patents, she has made significant contributions to the pharmaceutical field, particularly focusing on the development of chymase inhibitors. Her work reflects a commitment to innovating treatments for various diseases, marking her as a key figure in her industry.

Latest Patents

Among her latest innovations are two notable patents: the Benzimidazolone chymase inhibitors and the Aza-benzimidazolone chymase inhibitors. The former discloses small molecule inhibitors that hold promise in treating conditions associated with chymase, while the latter includes similar small molecule inhibitors and their pharmaceutical compositions, as well as processes for their production. Both patents emphasize the potential of these compounds in advancing therapeutic options for patients.

Career Highlights

Jin Mi Kim has accumulated substantial experience throughout her career, particularly through her tenure at Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH. These roles have provided her with unique insights into drug development and innovation, enabling her to bring her ideas to fruition. Her extensive background in the pharmaceutical industry is a testament to her expertise and dedication.

Collaborations

Throughout her career, Jin has collaborated with notable colleagues, including René Marc Lemieux and Terence Alfred Kelly. These partnerships have played a crucial role in the research and development processes, allowing for innovative ideas to be shared and enhanced in the pursuit of cutting-edge solutions in the pharmaceutical realm.

Conclusion

Jin Mi Kim exemplifies the spirit of innovation, with her groundbreaking patents paving the way for new treatments involving chymase inhibitors. Her work not only reflects her individual achievements but also highlights the power of collaboration within the scientific community. As she continues to advance her research, the impact of her contributions is sure to be felt in the healthcare industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…